Connie Hoy October 2013
|
|
- Jayson Paul
- 6 years ago
- Views:
Transcription
1 Connie Hoy October 2013
2 Warning letter issued to firm for complaint handling Failure to report within 30 days Failure to implement adequate procedures Failure to establish standard review process No procedure on how to fill out a 3500A Compliant SOP did not contain the address to send the 3500A Failure to properly identify the designated unit
3 No definition of a reportable event in the procedure No documentation on how the decision to report or not report is made No method for adequate follow up No corrective actions taken Failure to maintain adequate information in complaint files
4
5
6 Not aware of regulations Intentionally didn t file in order to hide serious adverse events Forgot
7 COMPANY BELIEVED THEY WERE IN COMPLIANCE
8 Failure to report within 30 days Failure to implement adequate procedures Failure to establish standard review process No definition of a reportable event in the procedure No documentation on how the decision to report or not report is made No method for adequate follow up No corrective actions taken Failure to maintain adequate information in complaint files
9
10 International Organization Management OUS Headquarters OUS Mfg OUS OPS OUS Marketing OUS Engineering OUS Designated Unit OUS RA/QA OUS Management Rep Doc Control OUS
11 US Operation US Subsidiary US Call Center Sales in US
12 Subsidiary establishment listing was for Manufacturer
13 Manufacturers of medical devices are required to report a device-related death, serious injury, or malfunction within 30 days after becoming aware of the event. Manufacturers are required to establish and maintain files related to reportable events. Manufacturers must develop, implement, and maintain written procedures for reporting adverse medical device events.
14 No agreement or procedure between the headquarters and the subsidiary that showed responsibility for complaints, adverse event investigation, reporting
15 Complaint handling procedures did exist but only at the headquarters level Due to the time difference, the US office could not obtain the procedures until the 2 nd day of the inspection US Call Center personnel were not aware of the existence of procedures
16 Procedures were not written in English This is amajor prob lem And they got inaal skdjqo tyrueieop Poer ywuqtiv
17 When US call center was asked what they do when they become aware of a potential adverse event they replied: I tell the General Manager (a sales person) When General Manager was asked for next step he replied: I headquarters
18 No AE Event files to review because they were located in a foreign country Took another day to get a list of investigated AE Took another day to get copies of the files Files were not written in English
19 Some of the Adverse events were filed late >30 days
20 What is the best way to prevent a warning letter?
21 DO NOT GET A 483
22 Importer - Takes first title to devices imported into the U.S. An Initial Importer must have a U.S. address (21 CFR ) Distributor means any person (other than the manufacturer or the initial importer) who distributes a device from the original place of manufacture to the person who makes the final delivery or sale of the device to the ultimate consumer or user.
23 FDA Inspector came to facility expecting to find a manufacturer with meeting all Quality System and regulatory Requirements Importers and distributors may be able to obtain MDR exemption
24 Apply for an MDR Exemption FDA may, upon written request or at its own discretion.grant to user facilities or manufacturers an exemption, variance, or alternative form of reporting from any or all of the reporting requirements Medwatch regulation(8)
25 Complaint handling procedure in English Relationship with US office to Hq Role of US call center Role of Designated Unit Basic, documented training for Call Center / Sales people on adverse events Script of questions for obtaining immediate Information (form) Timeframe to report AE to designated unit
26 Copy (paper or ecopy) of investigations 21 CFR (g) If a manufacturer's formally designated complaint unit is located outside of the United States, records required by this section shall be reasonably accessible in the United States at either: (1) A location in the United States where the manufacturer's records are regularly kept; or (2) The location of the initial distributor
27 Designated unit in US office Procedures (English) for complaint handling and AE investigation Original files in US office Copy sent to HQ
28 Jump into action Changed their establishment type Applied for an exemption from reporting Had the Designated unit (OUS) file the late MDRs Provided Corrective action with in 10 days SOPs in English defining a compliant process Form for collecting AE information during call point Training Records for Call Center
29
30 Received an exemption from MDR Reporting Sent copy of the exemption approval to the District Office
31 160 Days had passed since the initial 483 was issued 145 Days had passed since the initial response was sent to the district office
32 Corrective Action was insufficient Response was inadequate They were given an exemption for the very thing they now had received the warning letter
33 When they received the exemption they should have: Sent a written reply to the District Office Asked for a meeting with the District Office Sent a written reply to the Office of Compliance Asked for a meeting with the Office of Compliance All of the above
34 This should have prevented the WL, right? Should they ask to have the WL Rescinded?
35 Is receiving an exemption for MDR Reporting adequate corrective action? My opinion: NO The exemption is for MDR Reporting because FDA is not interested in duplicate reporting It is NOT an exemption from complying with the regulation itself This company was not in compliance with the regulations as stated in 21 CFR 820
36 Doesn t really matter who files the piece of paper to the FDA The most important tasks are: Adequate investigation of the AE Identifying the root case Taking corrective action / preventive action Correct management of reportable events Good documentation that is available to the FDA
37 Can these tasks be adequately performed by a designated unit that is OUS?
38
39
40 Well trained designated unit OUS Well defined process for investigation Well defined communication with the US office and the designated unit Adequate investigation leading to root cause and closure Availability of records to present to FDA (electronic) Link to Well Defined CAPA program
41 Well trained designated Unit in US Well defined process for feedback to headquarters Well defined process for investigation Well defined communication with the US office and the designated unit Adequate investigation leading to root cause and closure Availability of records to present to FDA (electronic) Link to Well Defined CAPA program
42 Designated Unit should remain OUS US office does not have appropriate technical capability to investigate
43 US office is only a sales office and call center Sales calls come into the office Sometimes report of an adverse event Sales people work out of this office Sometimes get report of an adverse event Ad hoc activity on how this gets handled Investigation is thwarted Time zone Language No gathering of initial information
44 FDA Inspector came to inspect manufacturer No procedures available and had to wait until day 2 to get SOPs SOPS not in English so they were verbally translated by the General Manager No records showing any type of investigation Investigator had to wait for copy of compliant files and they were not in English
45 Response contains a real solution to the handling of adverse events Exemption from filing an MDR Communication with the District office and Office of Compliance
46 DITTO
47
Complaint Handling and Medical Device Reporting (MDRs)
Complaint Handling and Medical Device Reporting (MDRs) FDA Small Business Regulatory Education for Industry (REdI) Bethesda, MD September 26, 2013 Andrew Xiao Consumer Safety Officer, Postmarket and Consumer
More information2015 Annual FDA Medical Device Quality System Data. Inspections, FDA Form 483 Observations, and Warning Letter Citations
2015 Annual FDA Medical Device Quality System Data Inspections, FDA Form 483 Observations, and Warning Letter Citations Why is FDA making these data available? In support of the FDA s Transparency and
More informationComplaints Investigation and Review. Dr. Ademola Daramola International Relations Specialist Drugs US FDA India Office New Delhi February 22nd 2018
Complaints Investigation and Review Dr. Ademola Daramola International Relations Specialist Drugs US FDA India Office New Delhi February 22nd 2018 Information presented in this presentation does not represent
More informationMedical Device Reporting. FD&C Act CFR Direct Final Rule 2/28/05. As amended by:
Medical Device Reporting Direct Final Rule 2/28/05 FD&C Act 519 As amended by: Safe Medical Devices Act of 1990 Medical Device Amendments of 1992 FDA Modernization Act of 1997 Authority to require manufacturers,
More informationClinical Research Seminar
Clinical Research Seminar HOW TO DEVELOP A CORRECTIVE AND PREVENTIVE ACTION PLAN (THAT EVEN THE IRB AND FDA WILL LOVE) April 11, 2018 Fiona Rice, MPH Human Research Quality Manager fionar@bu.edu Mary-Tara
More informationCBI s 14 th ANNUAL PRODUCT COMPLAINTS CONGRESS FOR LIFE SCIENCES June 14, 2016
CBI s 14 th ANNUAL PRODUCT COMPLAINTS CONGRESS FOR LIFE SCIENCES June 14, 2016 UPDATE ON FDA GUIDANCE AND REGULATIONS FOR THE COMPLAINT HANDLING PROCESS AND ON FDA FIELD ALERT REPORTS By Peter S. Reichertz
More informationModernizing Hospital Adverse Event Reporting
Modernizing Hospital Adverse Event Reporting 14 December 2016 Sarah H. Stec Not Legal Advice For Informational and Educational Purposes Only Firm Overview More than 1,500 lawyers in 46 offices across 21
More informationBE-595M Homework Assignment Due: 3/3/08
BE-595M Homework Assignment Due: 3/3/08 Attached is a Warning Letter issued to Applied Water Engineering, Inc., Salt Lake City, UT, for violations of the Quality System Regulations. The firm manufactures
More informationAn Educational Forum co-sponsored by the. US Food and Drug Administration. and the. FDA Medical Device Industry Coalition
An Educational Forum co-sponsored by the US Food and Drug Administration and the FDA Medical Device Industry Coalition June 15, 2012 Dallas, Texas USA Disclaimers The information provided in this workbook
More informationMedical Devices: Do I Need to Open a CAPA?
Medical Devices: Do I Need to Open a CAPA? Adrienne Franco Busby, Partner, Faegre Baker Daniels LLP Anne Miller, Principal Regulatory Counsel, Medtronic Marta L. Villarraga, Principal, Exponent, Inc. Moderated
More informationThe U.S. Food and Drug Administration s Food Safety Modernization Act: Current & Future Requirements
The U.S. Food and Drug Administration s Food Safety Modernization Act: Current & Future Requirements Beatrice Moreau Senior Regulatory Advisor Registrar Corp 144 Research Drive Hampton, Virginia USA 23666
More informationPREVENT YOUR DIETARY SUPPLEMENT LABORATORY FROM BECOMING A COMPLIANCE RISK. Marian Boardley 2013
PREVENT YOUR DIETARY SUPPLEMENT LABORATORY FROM BECOMING A COMPLIANCE RISK Marian Boardley 2013 APPLICABLE GMP S: DIETARY SUPPLEMENT LABS Subparts for laboratory operations and testing, 21 CFR 111 D Equipment
More informationRegulatory,Quality & Emergency Preparedness. MaryBeth Parache Director, Quality Affairs New York Blood Center
Regulatory,Quality & Emergency Preparedness MaryBeth Parache Director, Quality Affairs New York Blood Center 1 Regulatory 2 Who regulates us? Food and Drug Administration (FDA) Blood, tissue, HCT/P, medical
More informationInspections, Compliance, Enforcement, and Criminal Investigations
1 of 5 2/11/2014 11:24 AM Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations Baxter
More informationCenter for Drug Evaluation and Research - Compliance Central with FDA Center Compliance Directors: Part 1
Center for Drug Evaluation and Research - Compliance Central with FDA Center Compliance Directors: Part 1 Donald D. Ashley, JD 2017 FDLI Enforcement, Litigation, and Compliance Conference: For the Drug,
More informationLEGISLATION UPDATE & STATUS OF MCC / SAHPRA and GUIDANCE TO MEET REGULATOR S EXPECTATIONS
LEGISLATION UPDATE & STATUS OF MCC / SAHPRA and GUIDANCE TO MEET REGULATOR S EXPECTATIONS Joey Gouws MCC and Cluster: Food Control, Pharmaceutical Trade and Product Regulation NATIONAL DEPARTMENT OF HEALTH
More informationFDA s Office of Regulatory Affairs: Violation Trends & Medical Device Update
FDA s Office of Regulatory Affairs: Violation Trends & Medical Device Update Ginger M. Sykes Supervisory Consumer Safety Officer Salt Lake City Resident Post Office of Regulatory Affairs U.S. Food and
More informationGuide to Become a Licensed Commercial Ambulance Service in Maryland
Maryland Institute for Emergency Medical Services Systems State Office of Commercial Ambulance Licensing & Regulation 653 West Pratt Street, Room 313 Baltimore, MD 21201-1536 Office: (410) 706-8511 - Fax:
More informationPLAN OF ACTION FOR IMPLEMENTATION OF 510(K) AND SCIENCE RECOMMENDATIONS
PLAN OF ACTION FOR IMPLEMENTATION OF 510(K) AND SCIENCE RECOMMENDATIONS In August 2010, the Food and Drug Administration s Center for Devices and Radiological Health (CDRH or the Center) released for public
More informationSJN DO CB Field Alert Reports. Edwin Ramos Director of Compliance Food and Drug Administration San Juan District Office
SJN DO CB Field Alert Reports Edwin Ramos Director of Compliance Food and Drug Administration San Juan District Office SJN DO Mission Assuring that safe and effective drugs are available to the public
More informationChanging Requirements for Devices//Device Constituent Parts in Combination Products
Changing Requirements for Devices//Device Constituent Parts in Combination Products Dan Wozinski, RPH, MBA Sanofi Disclaimer The content and viewpoints of this presentation are mine alone and not those
More informationTexas Department of State Health Services
Texas Department of State Health Services DRUGS AND MEDICAL DEVICES GROUP WEB SITE: http://www.dshs.state.tx.us/dmd/ ISSUANCE OF CERTIFICATES OF FREE SALE AND SANITATION AND/OR CERTIFICATES OF ORIGIN AND
More informationToward Greater Scientific Rigor
Toward Greater Scientific Rigor Good Clinical Practice (GCP) A NEW REQUIREMENT! The Center for Clinical & Translational Science 205.934.7442 ccts@uab.edu www.uab.edu/ccts @cctsnetwork The requirement:
More informationFDA's OMB supporting document for QSr recordkeeping, 7/20/01, page 1 of 7
FDA's OMB supporting document for QSr recordkeeping, 7/20/01, page 1 of 7 DISCLAIMER: This document was prepared by editing the converted PDF file supporting FDA's request to OMB for continuation of record
More informationRoot Cause Analysis Practicum Human Factors Engineering Short Course
Learning Objectives Root Cause Analysis Practicum Human Factors Engineering Short Course 1. Identify human factors and other work system issues associated with an adverse event. 2. Develop a Cause-Effect
More informationAMENDED WARNING LETTER CIN
Department of Health and Human Services Public Health Service Food and Drug Administration Cincinnati District Office Central Region 6751 Steger Drive Cincinnati, OH 45237-3097 Telephone: (513) 679-2700
More informationMedical Device Reporting for Manufacturers
Medical Device Reporting for Manufacturers DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Food and Drug Administration Medical Device Reporting for Manufacturers Prepared by Division of
More informationDr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015
18 August 2015 Role & Responsibilities of Principal Dr. R. Sathianathan Professor of Psychiatry, SRMC, Porur & Former Director, Institute of Mental Health, Chennai Principal Investigators & GOOD CLINICAL
More informationPreparing for and responding to an FDA Inspection Frank Estala Kathy James Clara Vorpahl Anna Taranova
Preparing for and responding to an FDA Inspection Frank Estala Kathy James Clara Vorpahl Anna Taranova Disclosures The speakers have no relevant financial and non-financial relationships to disclose. The
More informationWARNING LETTER CERTIFIED MAIL -~ Q December 14, 2005
-~ Q DEPARTMENT Or HEALTI-I A\D HUMAN SERVICES Public Health Service Food and Drug Administration Central Region Telephone (973) 526-6006 New Jersey District Waterview Corporate Center 10 Waterview Blvd.,
More informationChanges to QSR. The table below provides a history of changes to FDA s Quality System Regulation (QSR)
Changes to QSR The table below provides a history of changes to FDA s Quality System Regulation (QSR) The citation is to the Federal R: the first number is the volume, FR indicates the Federal Register,
More informationWIRBinar. How to Survive an FDA Inspection. Upcoming Trainings: Contact Us: (360)
WIRBinar How to Survive an FDA Inspection 10-26-2011 Brought to you by WIRB Education and Consulting Services. Improve your ability to maintain compliance and protect human subjects with guidance from
More informationBristol Myers Squibb Holdings Pharma., Ltd.
Bristol Myers Squibb Holdings Pharma., Ltd. Department of Health and Human Services Public Health Service Food and Drug Administration 466 Fernandez Juncos Avenue Puerta De Tierra San Juan, Puerto Rico
More informationSPONSOR-INVESTIGATOR ROLES & RESPONSIBILITIES IN DEVICE TRIALS
SPONSOR-INVESTIGATOR ROLES & RESPONSIBILITIES IN DEVICE TRIALS Food and Drug Administration Center for Devices and Radiological Health Office of Compliance Division of Bioresearch Monitoring Doreen Kezer,
More informationResearch Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review
Effective: 12/04/2013 Reviewed: 12/04/2015 Name of Associated Policy: Palmetto Health Administrative Research Review Definitions Responsible Positions Equipment Needed Procedure Steps, Guidelines, Rules,
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Inspections, Compliance, Enforcement, and Criminal Investigations Husain, Mustafa M, M.D. 23-Jul-08 Department of Health and Human Services Public Health Service Food and Drug Administration Center for
More informationONADE s Data Quality Review
ONADE s Data Quality Review Office of New Animal Drug Evaluation Center for Veterinary Medicine Regulatory Affairs in Animal Health Seminar Kansas State University Olathe March 06, 2018 Presenter: Ana
More informationFDA Inspectional Process in Clinical Research An FDA Perspective. Annette Melendez, MPHsN Investigator Office of Biological Products Operations
FDA Inspectional Process in Clinical Research An FDA Perspective Annette Melendez, MPHsN Investigator Office of Biological Products Operations Outline BIMO PROGRAM OVERVIEW PROGRAM COVERED AREAS INSPECTIONAL
More informationCenter for Devices and Radiological Health; Medical Devices and Combination Products;
This document is scheduled to be published in the Federal Register on 12/26/2017 and available online at https://federalregister.gov/d/2017-27650, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
More informationNew England District Update FDA s Office of Regulatory Affairs Aligns for the Future
New England District Update FDA s Office of Regulatory Affairs Aligns for the Future MassMedic December 12, 2017 Waltham, MA Joseph S. Matrisciano Jr, JD, PE Director, New England District Director, Office
More informationOBSERVATIONS AND RESPONSES
OBSERVATIONS AND RESPONSES PERSONNEL 98 1- During verification of the training program, discrepancies were found in the mechanism to ensure that all employees concerned are trained on controlled documents
More informationQUALITY TIPS FOR CLINICAL SITES. Athena Thomas-Visel. Clinical Quality Consultant QUALITY TIPS FOR CLINICAL SITES
QUALITY TIPS FOR CLINICAL SITES Athena Thomas-Visel Clinical Quality Consultant QUALITY TIPS FOR CLINICAL SITES Purpose of presentation: Share best practices seen from 150+ sites visited Spark conversation
More informationWe are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.
Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Sheepwalk House 39 Sheepwalk Lane, Ravenshead, Nottingham, NG15
More informationDocumenting the Story of a Clinical Trial: Concept to CAPA. Lori T. Gilmartin Gilmartin Consulting LLC
Documenting the Story of a Clinical Trial: Concept to CAPA Lori T. Gilmartin Gilmartin Consulting LLC The regulations represent the floor while ethical thinking is the sky. Dr. Thomas Moore Boston University
More informationEstablishment Registration and Device Listing. Michelle C. Jackson, Esq. Partner Venable LLP
Establishment Registration and Device Listing Michelle C. Jackson, Esq. Partner Venable LLP Learning Objectives Statutory Basis for Registration and Listing Relevant Regulations Who Must Register and List
More informationSession 3 FDA Audits and Findings
Session 3 FDA Audits and Findings Byungja Marciante, Investigator US Food and Drug Administration Shanghai Centre-Suite 723 1376 Nanjing Xi Lu Shanghai, PRC 200040 美国食品药品管理局上海商城 723 室南京西路 1376 号中国上海 200040
More informationWe are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.
Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Sussex Health Care Audiology Ltd Dorking Hospital, Horsham Road,
More informationUniversity of Colorado Denver Human Research Protection Program Investigator Responsibilities for the Protection of Human Subjects
Institutional Guidelines The Colorado Multiple Institutional Review Board (COMIRB) recently reviewed and approved your research. The COMIRB reviews research to ensure that the federal regulations for protecting
More informationPediatric Medical Device Development and Safety. Jacqueline N. Francis, MD, MPH Medical Officer, PSRB, ODE, CDRH, FDA
Pediatric Medical Device Development and Safety Jacqueline N. Francis, MD, MPH Medical Officer, PSRB, ODE, CDRH, FDA This presentation represents the professional opinion of the speaker and is not an official
More informationFDA Inspection Readiness
FDA Inspection Readiness Richard Angelo, Ph.D. Director, Managing Consultant October 17, 2014 Agenda Reasons for Inspections Preparing for Inspections Inspection Day Inspection Outcomes 2013 Inspection
More informationCertification Scheme for a Certificate of Pharmaceutical Product (CPP) IFPMA CPP Network Training Toolkit
Certification Scheme for a Certificate of Pharmaceutical Product (CPP) IFPMA CPP Network Training Toolkit 01 Training package Why is training needed? Training modules CPP overview CPP scenario training
More informationWARNING LETTER VIA FEDERAL EXPRES S
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville, Maryland 20850 WARNING LETTER VIA FEDERAL EPRES S George W. LeMaitre Chairman
More informationGeneral Administration GA STANDARD OPERATING PROCEDURE ON SOPs: Preparing, Maintaining and Training
Replaces previous version 101.00: 01 April 2012 General Administration GA 101.01 STANDARD OPERATING PROCEDURE ON SOPs: Preparing, Maintaining and Training Approval: Nancy M. Paris, MS, FACHE President
More informationWe are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.
Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Allied Healthcare Portsmouth Ground Floor, Admiral House, 8A
More informationWe are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.
Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Turning Point Hertfordshire Community Mental Health Services
More informationGood Clinical Practice: A Ground Level View
Good Clinical Practice: A Ground Level View Jeanna Julo, BA, BA, CCRP Assistant Director, Clinical Data Management & Quality Controls, Auditing & Training Clinical Research Administration Research Institute,
More informationCHABOT/LAS POSITAS COMMUNITY COLLEGE DISTRICT
CHABOT/LAS POSITAS COMMUNITY COLLEGE DISTRICT HAZARD COMMUNICATION PLAN Chabot/Las Positas Community College District Hazard Communication Program 2/2007 Pg 1 of 7 Hazard Communication Program Policy Policy
More information:,-, WARNING LETTER. Mr. Jean Claude Mas Chief Executive Officer Poly Implants Protheses, Sa 337 Avenue De Bruxelles La Seyne, Sur Mer France
+., %- *: $1.,X,, *,+,,r + $, DEPARTMENT +, %, >,,, :,-, OF HEALTH & HUMAN SERVICES Public Health Service VIA FEDERAL EXPRESS ~ 22moo WARNING LETTER Mr. Jean Claude Mas Chief Executive Officer Poly Implants
More informationGood Documentation Practices. Human Subject Research. for
Good Documentation Practices for Human Subject Research Bridget M. Psicihulis, RHIA, CCRC Quality Improvement Unit Coordinator Human Research Protection Program Wheaton Franciscan Healthcare (last updated
More informationFOIA PROCESS EXECUTIVE SUMMARY
FOIA PROCESS EXECUTIVE SUMMARY The Freedom of Information Act (FOIA) requests that we reviewed appeared to be processed generally in compliance with the FOIA. Some areas needed improvement, as discussed
More informationDepartment of Defense Human Research Protection Program DOD INSTITUTIONAL AGREEMENT FOR INSTITUTIONAL REVIEW BOARD (IRB) REVIEW (IAIR)
Department of Defense Human Research Protection Program DOD INSTITUTIONAL AGREEMENT FOR INSTITUTIONAL REVIEW BOARD (IRB) REVIEW (IAIR) General Instructions to Institutions and IRBs This form should be
More informationEMA Inspection Site perspective
EMA Inspection Site perspective Hermien Gous Wits RHI Shandukani Research Centre 27.09.2016 Cape Town Why were we inspected times? Pharmaceutical company applied for registration of the study drug in a
More informationSJMHS SAFE MEDICAL DEVICE ACT (SMDA) 7/2017
SJMHS SAFE MEDICAL DEVICE ACT (SMDA) 7/2017 2 Objectives Upon completion of this course you should be able to: Describe the steps to take to report an adverse event with a medical device at your site Locate
More informationGeneral Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility
General Administration GA 102.01 STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility Approval: Nancy Paris, MS, FACHE President and CEO (17 July 2014) (Signature and
More informationSection 5 BMP Implementation and Evaluation 5.1 Introduction
5.1 Introduction As noted in Section 1 each municipality regulated under stormwater NPDES permits, whether categorized as a Phase I or Phase II municipality, is required to implement a stormwater management
More informationInvestigator Roles and Responsibilities in Clinical Device Trials
Investigator Roles and Responsibilities in Clinical Device Trials A Total Product Lifecycle Approach to Medical Device Development: Responsibilities and Opportunities The Stanford Center for Clinical and
More informationWe are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.
Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Sale Moor Dental Practice 15 Marsland Road, Sale, M33 3HP Tel:
More informationDelegation Agreement Between and. Minnesota Department of Health
Delegation Agreement Between and Minnesota Department of Health This Agreement, effective on the first day of, 20, is between the State of Minnesota acting through its Commissioner of Health ( Minnesota
More informationWe are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.
Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Newhaven Care 20 Penkett Road, Wallasey, CH45 7QN Tel: 01516305584
More informationVersion 1.1, 6/30/2016 Guidance for Abbreviated IDE Requirements
Version 1.1, 6/30/2016 Guidance for Abbreviated IDE Requirements The Principal Investigator of a study that is requesting an abbreviated IDE for use of a non-significant risk device must attest to the
More informationMedicare Program; Announcement of the Reapproval of the Joint Commission as an
This document is scheduled to be published in the Federal Register on 05/25/2018 and available online at https://federalregister.gov/d/2018-11330, and on FDsys.gov [Billing Code: 4120-01-P] DEPARTMENT
More informationReceived an RTA Deficiency List or AI Letter? Now What?
Received an RTA Deficiency List or AI Letter? Now What? Dealing with Unexpected Issues/Questions during the Submission Review Process Navigating Submission Challenges to reduce time & risk September 26,
More informationAFDO FINAL COMMITTEE REPORT
2013-2014 AFDO FINAL COMMITTEE REPORT International & Governmental Relations Committee *Chair: Mark Roh, U.S. Food & Drug Administration, Oakland, CA Chair: Bob Scales, Health Products & Food Branch, Health
More informationWe are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.
Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Dr Lona Sabeti-Shanmuganathan - Carnforth 29A Market Street,
More informationWe are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.
Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. London Orthopaedic & Sports Medicine Centre 17 Fitzhardinge
More informationDEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
60-4 (v4 ( ~' DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service. Food and Drug Administration 9200 Corporate Boulevard el Rockville, Maryland 20850 MAY - 6 2008 VIA FEDERAL EXPRES S Merrill W.
More informationCORRECTIVE ACTION REQUEST
1.0 PURPOSE CORRECTIVE ACTION REQUEST To establish a method for prompt documentation and correction of significant conditions adverse to quality. 2.0 APPLICABILITY This procedure applies to all General
More informationSTUDY INFORMATION POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812)
POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812) Purpose: Investigators who initiate and submit an IDE application to the FDA assume the responsibilities of both
More informationDetermining and Reporting Adverse Events vs. Product Complaints
Determining and Reporting Adverse Events vs. Product Complaints Pharma Perspective: Jacqueline Grissinger Director, Office of Consumer Medical Safety Johnson & Johnson Medical Device Perspective: Lisa
More information4.2. Clinical Trial Monitor (or Monitor): The person responsible for monitoring the data on behalf of the sponsor or contract research organization.
SOP #: MON-101 Page: 1 of 6 1. POLICY STATEMENT: The DF/HCC understands that external sponsors are required to monitor the progress of clinical investigations and ensure appropriate research data collection
More informationFINAL DOCUMENT. Global Harmonization Task Force
GHTF/SG5/N5:2012 FINAL DOCUMENT Global Harmonization Task Force Title: Reportable Events During Pre-Market Clinical Investigations Authoring Group: Study Group 5 of the Global Harmonization Task Force
More informationRemediation, Resolution and Outcomes
IPA Pharmaceutical Forum 2018 22-23 February 2018 Presented by Andrei Spinei Manufacturing and Quality Compliance, European Medicines Agency An agency of the European Union Contents 1.EMA EU Network 2.Remediation
More informationQuality Assurance and Regulatory Compliance Office and USAMRIID FDA Risk Management. Carolyn Mentzer Chief, QARCO
Quality Assurance and Regulatory Compliance Office and USAMRIID FDA Risk Management Carolyn Mentzer Chief, QARCO 301-619-3422 Who We Are and What We Do USAMRIID s mission is to conduct basic and applied
More informationThe Cutting Edge Food Safety Management Partnership
The Cutting Edge Food Safety Management Partnership Verify Results Train Staff Establish Policy MARICOPA COUNTY ENVIRONMENTAL SERVICES DEPARTMENT Maricopa County is the 6 th largest County housing 4 million
More information2018 UPDATES BUREAU OF HUMAN SERVICES LICENSING
2018 UPDATES Jacqueline Rowe, Director, MA, BS, NHA Jill Kachmar, Regulatory Licensing Manager 1 DHS Updates DHS Secretary Teresa Miller Confirmed DHS Office of Administration Deputy Secretary Carolyn
More informationSolutions for GCP Compliance Challenges. September 23, 2015 Northwestern University IRB Brown Bag Session
Solutions for GCP Compliance Challenges September 23, 2015 Northwestern University IRB Brown Bag Session PAMELA MASON, MPH Vice President, Mason Professional Services, LLC Adjunct Faculty, Northwestern
More informationSolutions for GCP Compliance Challenges
Solutions for GCP Compliance Challenges September 23, 2015 Northwestern University IRB Brown Bag Session PAMELA MASON, MPH Vice President, Mason Professional Services, LLC Adjunct Faculty, Northwestern
More informationU. S. Coast Guard Sector
U. S. Coast Guard Sector Auxiliary Assistant Suspension and Revocation Investigator Performance Qualification Standard [This page left intentionally blank] Sector Training Guide Auxiliary Assistant Suspension
More informationUnderstanding USP 797
Baxa Corporation Understanding USP 797 Technical Paper An Overview of USP General Chapter Pharmaceutical Compounding Sterile Preparations Mike Hurst, RPh, MBA 2004 Baxa Corporation Introduction USP
More informationWe are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.
Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. The Elms Dental Practice 256 Norcot Road, Tilehurst, Reading,
More informationClinical Research Professionals
Training & Resources for Clinical Research Professionals Course & Publications Catalog January July 2016 In-Person and Web-Based Training Courses, Customized Training, elearning and Publications for Clinical
More informationWe are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.
Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Soma Healthcare (East London) 17 Beaufort Court, Admiral Way,
More informationFDA Medical Device Regulations vs. ISO 14155
Vol. 11, No. 9, September 2015 Happy Trials to You FDA Medical Device Regulations vs. ISO 14155 By Shawn Kennedy Medical device clinical trials must comply with 21 CFR Parts 11 (Electronic Records), 50
More informationWe are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.
Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Thorpe House Nursing Home Limited 20-22 Finthorpe Lane, Almondbury,
More informationWe are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.
Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. St Blaise 2 St Blaise Avenue, Bromley, Kent, BR1 3DA Tel: 02084601851
More informationWe are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.
Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Helping Hand Care Company Ltd Office 5, 23-25 Worthington Street,
More informationSeptember 2-3, 2013 Chengdu, China
Root Cause Investigations and Corrective Actions for GCP Compliance September 2-3, 2013 Chengdu, China Good Clinical Practice (GCP) is a compilation of best practices and quality standards to be applied
More informationOFFICE OF AUDIT REGION 9 f LOS ANGELES, CA. Office of Native American Programs, Washington, DC
OFFICE OF AUDIT REGION 9 f LOS ANGELES, CA Office of Native American Programs, Washington, DC 2012-LA-0005 SEPTEMBER 28, 2012 Issue Date: September 28, 2012 Audit Report Number: 2012-LA-0005 TO: Rodger
More informationClinical Trial Quality Assurance Common Findings
Clinical Trial Quality Assurance Common Findings Objectives Identify common findings found in research study reviews conducted by the CTQA Program Understand what findings require an action plan vs. a
More informationPathway Resource Centre Care Home Service Children and Young People Meadow Mill Tranent EH33 1DT Telephone:
Pathway Resource Centre Care Home Service Children and Young People Meadow Mill Tranent EH33 1DT Telephone: 01875 610794 Inspected by: Iain Lamb Type of inspection: Unannounced Inspection completed on:
More information